Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer.
Razis E, Dimopoulos AM, Bafaloukos D, Papadimitriou C, Kalogera-Fountzila A, Kalofonos H, Briassoulis E, Samantas E, Keramopoulos A, Pavlidis N, Kosmidis P, Fountzilas G.
Razis E, et al. Among authors: pavlidis n.
Cancer Invest. 2001;19(2):137-44. doi: 10.1081/cnv-100000148.
Cancer Invest. 2001.
PMID: 11296618
Clinical Trial.